Top Gainers and Losers on May 30, 2025: Eternal Leads Gains, Bajaj Auto Drags

On May 30, 2025, the BSE Sensex ended lower by 182.01 points to close at 81,451.01, while the Nifty 50 fell 82.90 points, settling at 24,750.70.

Broad-based weakness was observed across key sectors, with pressure seen in auto and IT stocks. Gains in select banking and pharma counters helped limit deeper losses.

Top Gainers of the Day

1. Eternal

Eternal surged 4.98%, opening at ₹226.56 and hitting a high of ₹243 before closing at ₹239.75. The stock saw strong volume with over 46 crore shares traded.

2. State Bank of India 

SBIN rose 2.09%, moving from an open of ₹798.00 to close at ₹814 after hitting a high of ₹814.50.

3. HDFC Bank

HDFC Bank gained 0.73%, trading between ₹1,925.40 and ₹1,948.80, before settling at ₹1,941.50.

4. Larsen & Toubro

LT added 0.46%, closing at ₹3,672 after an intraday high of ₹3,695.30.

5. Dr. Reddy’s Laboratories

Dr. Reddy’s ended 0.22% higher, closing at ₹1,251.00 after trading between ₹1,241.00 and ₹1,257.60.

Top Losers of the Day

1. Bajaj Auto

Bajaj Auto dropped 3.10%, closing at ₹8,599 after hitting an intraday low of ₹8,585.

2. Hindalco

Hindalco slipped 2.51%, trading between ₹632.15 and ₹650.90 before closing at ₹633.70.

3. HCL Technologies

HCLTech fell 1.99%, closing at ₹1,631.50. The stock saw downward pressure throughout the day.

4. Shriram Finance

Shriram Finance declined 1.98%, ending the session at ₹639.35 after touching a high of ₹654.95.

5. Tech Mahindra

Tech Mahindra eased 1.69%, closing at ₹1,573 after ranging between ₹1,568 and ₹1,595.

Read More: Key Trends to Watch in June 2025: RBI MPC Meeting, Inflation Data and More.

Conclusion

Equity markets ended lower on May 30, 2025, amid global uncertainty and sectoral weakness, particularly in auto and IT. While select banking and pharma stocks provided support, overall sentiment remained cautious.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities market are subject to market risks, read all the related documents carefully before investing.